Concepedia

James Mather

JM

Statistics

Publications

5

Citations

422

H-Index

5

Active since

2010

Affiliations

Knopp Biosciences (United States)(Current)

Massachusetts General Hospital

Columbia University Irving Medical Center

James Mather is an author at Knopp Biosciences (United States) specializing in medicine, pharmacology, and neuropharmacology.

Publications per year

2010–2023

5

Publications

5

The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis

Merit Cudkowicz, Michael Bozik, Evan W. Ingersoll et al. · Nature Medicine · 2011 · 179 citations

, , +11

Proximal humerus cortical bone thickness correlates with bone mineral density and can clinically rule out osteoporosis

James Mather, Joy C. MacDermid, Kenneth J. Faber et al. · Journal of Shoulder and Elbow Surgery · 2012 · 128 citations

, , +13

A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS

Michael Bozik, Hiroshi Mitsumoto, Benjamin Rix Brooks et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2014 · 51 citations

, , +14

Safety, Tolerability, and Pharmacokinetics of KNS-760704 (Dexpramipexole) in Healthy Adult Subjects

Michael Bozik, James Mather, William G. Kramer et al. · The Journal of Clinical Pharmacology · 2010 · 41 citations

, , +15

Safety and Efficacy of Dexpramipexole in Eosinophilic Asthma (EXHALE): A randomized controlled trial

Salman Siddiqui, Sally E. Wenzel, Michael Bozik et al. · Journal of Allergy and Clinical Immunology · 2023 · 23 citations · Full text

, , +14

1–5 of 5